Group: Skin & Superficial Tumours
Malignant Melanoma
In this portal's corpus, cutaneous and subcutaneous melanoma metastases are the single tumour type with the most publications for electrochemotherapy. The method has been studied for local control in numerous, recurrent lesions unsuited to surgery. Current research examines the effect of combining ECT with immune checkpoint inhibitors on local and systemic tumour responses.
193publication records190 unique studies once versions are merged
78clinical publication records
75preclinical publication records
30reviews
1995–2026publication span
Clinical publications: randomized, prospective and retrospective studies, case series and case reports. Preclinical publications: animal, in vitro, modelling and experimental biophysics studies.
Clinical and Technical Data Reported in the Publications
The sum of the fields reported in the full text of 190 of the 193 publications in this area. The numbers are summed, not interpreted.
Sum of the patient counts reported across publications6,233 (reported in 83 publications)
Publications relating their cohort to other publicationspossible cohort overlap (3) · same cohort (1)
Total lesions reported20,168 (in 56 publications)
Devices used (107 publications naming a device)Cliniporator (43) · BTX ECM830 (8) · GT-01 (7) · ELECTRO CELL B10 (6) · Jouan GHT 1287 (3) · MedPulser (3)
Agent delivered and route (161 publications reporting an agent)bleomycin · intravenous (63) · plasmid DNA · intratumoural (21) · bleomycin (21) · bleomycin · intratumoural (13) · bleomycin · both intravenous and intratumoural (10) · plasmid DNA (5)
Approach (105 publications report it)percutaneous (62) · transcutaneous surface (39) · intraoperative (2) · endoscopic (1) · open surgical (1)
Image guidance (70 publications report it)direct vision (53) · ultrasound (14) · computed tomography (4) · PET-CT (3) · endoscopy (2)
Response criteria (84 publications report it)clinical examination (31) · other (14) · RECIST (14) · WHO criteria (9) · RECIST 1.1 (7)
Combination therapy (113 publications report it)systemic chemotherapy (38) · other immunotherapy (34) · other combination (32) · checkpoint inhibitor (22) · radiotherapy (10)
Publications reporting retreatment67 of 136 publications (54 do not report it)
Field strength40–12600 V/cm (82 records, median 1125)
Applied voltage240–3000 V (18 records, median 910)
Number of pulses1–480 (99 records, median 8)
Pulse duration0.4–100000 µs (103 records, median 100)
The totals are not a count of unique patients: the same cohort may have been reported in more than one publication.
Literature Status by Method
Publication count, clinical and preclinical split, literature volume and publication span for each clinical method. The badge at the top of the page summarises the ECT record only; the full split by method is here.
Electrochemotherapy (ECT)
124publication records
69clinical publication records
27preclinical publication records
Limited clinical publication volumethreshold 18/124 records
Clinical and preclinical split of that figure: 7 clinical, 6 preclinical.
1996–2026
Irreversible electroporation (IRE)
6publication records
0clinical publication records
5preclinical publication records
Exploratory / low-volume literaturethreshold 0/6 records
No record for this method feeds the volume label.
2013–2025
Calcium electroporation
8publication records
3clinical publication records
5preclinical publication records
Exploratory / low-volume literaturethreshold 0/8 records
No record for this method feeds the volume label.
2017–2024
Gene electrotransfer
24publication records
1clinical publication records
22preclinical publication records
Exploratory / low-volume literaturethreshold 0/24 records
No record for this method feeds the volume label.
2008–2025
Other electroporation applications
31publication records
5clinical publication records
16preclinical publication records
This set does not name a single clinical method; no literature volume is assigned.
1995–2025
Mechanisms Mentioned in Abstracts
The figure is the number of abstracts mentioning the mechanism. A mention does not mean it was demonstrated in that study.
Increased Intracellular Bleomycin Accumulation 59
Gene Electrotransfer (Plasmid DNA) 33
Interleukin-12 Mediated Immune Stimulation 23
Immune Checkpoint Inhibitor Combination 23
Reversible Membrane Permeabilisation 22
Potentiation of Cytotoxic Drug Permeability 19
Increased Intracellular Cisplatin Accumulation 17
Necrosis and Necroptosis 17
Apoptosis Induction 16
Systemic / Abscopal Immune Response 15
Optimisation of Pulse Parameters 13
Muscle Contraction and Anaesthesia Requirement 10
Study Type Distribution
The percentage gives the share of the whole area.
| Study type | Publications | Share within this area |
|---|---|---|
| Randomized Clinical Trial | 2 | 1% |
| Prospective Clinical Study | 3 | 2% |
| Clinical Study | 37 | 19% |
| Retrospective Clinical Study | 11 | 6% |
| Case Series | 3 | 2% |
| Case Report | 22 | 11% |
| Systematic Review / Meta-Analysis | 4 | 2% |
| Guideline / Consensus | 2 | 1% |
| Review | 26 | 13% |
| Animal Study | 54 | 28% |
| In Vitro Study | 20 | 10% |
| Experimental Biophysics Study | 1 | <1% |
| Survey / Field Study | 1 | <1% |
| Conference Abstract | 1 | <1% |
| Editorial / Letter | 5 | 3% |
| Correction / Erratum | 1 | <1% |
Publication Table
193 publication records sorted by study design. Click a title to open the citation, mechanism and full abstract drawer.
Classifications are generated automatically and can be wrong for individual records. Methodology
| Regime | Publication | Year | Study type | Model | Mechanism | Patients / lesions | Device | Agent and route | Reported outcome | Abstract |
|---|---|---|---|---|---|---|---|---|---|---|
| ECT | Gaudy et al · J Cutan Med Surg | 2006 | Randomized Clinical Trial | Human | Increased Intracellular Bleomycin Accumulation | 12 / 54 | MedPulser | bleomycin · intratumoural | – | Background: Electrochemotherapy (ECT) combines intralesional injections of bleomycin with electroporation (EP), which permeabilizes tumor cells and thus increases the bleomycin efficacy at t… |
| ECT | Byrne et al · Melanoma Res | 2005 | Randomized Clinical Trial | Human | Increased Intracellular Bleomycin Accumulation | 19 / 18 | MedPulser | bleomycin · intratumoural | objective response 78% (18 lesions) | Electroporation therapy (EPT) is a novel treatment modality that uses brief, high-intensity, pulsed electrical currents to enhance the uptake of chemotherapeutic agents, vaccines and genes i… |
| ECT | Rózsa et al · Dermatologic Therapy | 2025 | Prospective Clinical Study | Human | Increased Intracellular Bleomycin Accumulation | 44 / 339 | Cliniporator | bleomycin · intravenous | objective response 71% (82 lesions) | Introduction: Immunosuppressed patients face a significantly higher risk of developing malignant skin tumors compared to the general population, often presenting with numerous, rapidly growi… |
| Other EP | Theurich et al · Cancer Immunol Res | 2016 | Prospective Clinical Study | Human | Immune Checkpoint Inhibitor Combination, Systemic / Abscopal Immune Response | 127 / 137 | – | – | objective response 0.378 ratio (45 patients) | Immune checkpoint inhibition with ipilimumab has revolutionized cancer immunotherapy and significantly improved outcomes of patients with advanced malignant melanoma. Local peripheral treatm… |
| ECT | Simeone et al · J Transl Med | 2014 | Prospective Clinical Study | Human | Immune Checkpoint Inhibitor Combination, Systemic / Abscopal Immune Response | 15 | – | bleomycin | complete response 4 count (10 patients) | Ipilimumab is the first agent approved for the treatment of advanced melanoma that showed a survival benefit in randomized phase 3 trials. Despite the survival benefit, due to its mechanism … |
| ECT | Kempa-Kamińska et al · EJC Skin Cancer | 2026 | Clinical Study | Human | – | 1 | – | bleomycin · intravenous | – | This publication has no abstract. |
| ECT | Kis et al · Clin Exp Metastasis | 2025 | Clinical Study | Human | Immune Checkpoint Inhibitor Combination | 170 | square wave electric pulse generator | bleomycin · both intravenous and intratumoural | – | Published data on the combination of immunotherapy and electrochemotherapy (ECT) consistently indicate a benefit in tumor response, but an important question, the optimal timing for combinat… |
| ECT | Caballero-Borrego et al · Braz J Otorhinolaryngol | 2024 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation | 56 | – | bleomycin · intravenous | objective response 84% (56 patients) | Objectives: To evaluate the efficacy and tolerance after the electrochemotherapy treatment for local therapy of cutaneous and subcutaneous metastases of head-and-neck tumors and malignant me… |
| Calcium EP | Vissing · Acta Oncol | 2024 | Clinical Study | Human | Necrosis and Necroptosis, Systemic / Abscopal Immune Response | 17 / 49 | Cliniporator | calcium chloride · intratumoural | objective response 58.6% (29 lesions) | Background and purpose: Calcium electroporation (CaEP) involves injecting calcium into tumour tissues and using electrical pulses to create membrane pores that induce cell death. This study … |
| ECT | Ziętek et al · Postepy Dermatol Alergol | 2022 | Clinical Study | Human | – | 5 / 200 | Cliniporator, EPS02 | bleomycin · intravenous | objective response 66.7 months (5 patients) | Introduction: Patients with cutaneous malignant melanoma (MM), in case of non-resectability of the lesions, have only a limited pool of the available treatment options. In recent years espec… |
| ECT | Sersa et al · European Journal of Surgical Oncology | 2021 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation | 61 | – | bleomycin · both intravenous and intratumoural | complete response 57.4% (61 patients) | While the risks associated with sentinel lymph node (SLN) biopsy in the regional nodal staging for malignant melanoma are low, efforts have been made at identifying patients in whom the proc… |
| ECT | Pirc et al · Clin Ther | 2020 | Clinical Study | Human | – | 23 | Cliniporator | bleomycin · intravenous | quality of life 0.29 score (23 patients) | Purpose: Electrochemotherapy is increasingly entering into national and international guidelines, requiring formal evaluation of treatment costs and cost-effectiveness to ensure that its upt… |
| Other EP | Ascierto et al · J Transl Med | 2020 | Clinical Study | Human | Potentiation of Cytotoxic Drug Permeability, Immune Checkpoint Inhibitor Combination | 376 | – | bleomycin | overall survival 88% (376 patients) | The melanoma treatment landscape changed in 2011 with the approval of the first anti-cytotoxic T-lymphocyte-associated protein (CTLA)-4 checkpoint inhibitor and of the first BRAF-targeted mo… |
| ECT | Jamsek et al · Radiol Oncol | 2020 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Reversible Membrane Permeabilisation | 28 / 52 | Cliniporator | bleomycin · intravenous | complete response 100% (24 lesions) | Background Electrochemotherapy (ECT) is a local cancer treatment based on electroporation where the electric field is used to enhance cell membrane permeability and thereby facilitating the … |
| ECT | Odili et al · European Journal of Surgical Oncology | 2019 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Muscle Contraction and Anaesthesia Requirement | 246 / 679 | – | bleomycin · both intravenous and intratumoural | objective response 80% (203 patients) | Basal cell carcinoma(BCC) is one of the most common skin malignancies worldwide. In comparison to current management strategies for BCC, electrochemotherapy (ECT) proved to be a valid altern… |
| ECT | Kunte et al · Br J Dermatol | 2017 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Muscle Contraction and Anaesthesia Requirement | 114 / 394 | IGEA electroporator | bleomycin · intravenous | overall survival 67% (114 patients) | Background: (ECT) is an effective local treatment for cutaneous metastasis. Treatment involves the administration of chemotherapeutic drugs followed by delivery of electrical pulses to the t… |
| ECT | Bigi et al · Clin Cosmet Investig Dermatol | 2016 | Clinical Study | Human | Apoptosis Induction, Necrosis and Necroptosis | 2 / 21 | Cliniporator | bleomycin · intravenous | progressive disease 0 count (2 patients) | Background: Electrochemotherapy (ECT) is increasingly used in the treatment of primary and secondary skin tumors, but little is known about the pathologic mechanism responsible for tumor cel… |
| ECT | Di Gennaro et al · Clin Exp Metastasis | 2016 | Clinical Study | Human | Immunogenic Cell Death (ICD) | – | – | bleomycin | – | Electrochemotherapy (ECT) represents an effective local treatment for skin unresectable melanoma metastases with high overall objective response rate. ECT is based on the combination of anti… |
| ECT | Grau et al · Braz J Otorhinolaryngol | 2016 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Necrosis and Necroptosis | – | Cliniporator | bleomycin · intravenous | – | Introduction: Local progression of papillary thyroid carcinoma (PTC) after failure of standard therapies may cause pain, ulceration, and bleeding. As patients are fully aware of the tumor gr… |
| ECT | Mir-Bonafé et al · Actas Dermosifiliogr | 2015 | Clinical Study | Human | Necrosis and Necroptosis | 31 | Cliniporator | bleomycin · intravenous | complete response 23% (31 patients) | Introduction and objectives: Electrochemotherapy is indicated for the treatment of unresectable cutaneous and subcutaneous tumors. The technique involves the synergistic use of electroporati… |
| Other EP | Bhatia et al · European Journal of Cancer | 2015 | Clinical Study | Human | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | – | plasmid DNA · intratumoural | – | Interleukin-12 (IL-12), a master regulator of adaptive type-1 immunity, has demonstrated antitumor efficacy, but is associated with severe toxicities when administered systemically. Local IL-… |
| ECT | Caracò et al · Melanoma Manag | 2015 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation | 89 | Cliniporator | bleomycin · intravenous | objective response 67.5% (89 patients) | Aim: This study was undertaken to update the outcome of the treated lesions with electrochemotherapy (ECT) plus intravenous injection of bleomycin in patients with in-transit disease or dist… |
| ECT | Mir-Bonafé et al · Actas Dermo-Sifiliográficas (English Edition) | 2015 | Clinical Study | Human | Necrosis and Necroptosis | 31 | Cliniporator | bleomycin · intravenous | complete response 23% (31 patients) | Electrochemotherapy is indicated for the treatment of unresectable cutaneous and subcutaneous tumors. The technique involves the synergistic use of electroporation of cell membranes to incre… |
| ECT | Mozzillo et al · J Transl Med | 2014 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation | 60 | – | bleomycin · intravenous | objective response 86.6% (60 patients) | Background Treatment of early and multiple cutaneous unresectable recurrences is a major therapeutic problem with around 80% of patients relapsing within 5 years [1]. For lesions refractory … |
| ECT | Caracò et al · BMC Cancer | 2013 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation | 60 | Cliniporator | bleomycin · intravenous | objective response 86.6% (60 patients) | Background: Treatment of early and multiple cutaneous unresectable recurrences is a major therapeutic problem with around 80% of patients relapsing within 5 years. For lesions refractory to … |
| ECT | Ricotti et al · Dermatol Ther | 2013 | Clinical Study | Human | Muscle Contraction and Anaesthesia Requirement | 30 / 654 | Cliniporator | bleomycin · intravenous | objective response 100% (654 lesions) | Treatment of multiple cutaneous and subcutaneous melanoma metastases is still represents a therapeutic challenge for both dermatologists and oncologists. Electrochemotherapy (ECT) is a promi… |
| ECT | Campana et al · Br J Surg | 2012 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation | 85 / 894 | Cliniporator | bleomycin · both intravenous and intratumoural | complete response 48.1% (268 lesions) | Background: The aim of the study was to determine predictive factors for effectiveness, toxicity and local disease control in patients with malignant melanoma treated with bleomycin-based el… |
| ECT | Di Monta et al · European Journal of Surgical Oncology (EJSO) | 2012 | Clinical Study | Human | – | 1 / 1 | – | bleomycin | complete response 3 score (2 sessions) | This publication has no abstract. |
| ECT | Mozzillo et al · European Journal of Surgical Oncology (EJSO) | 2012 | Clinical Study | Human | – | 1 / 1 | – | bleomycin · intravenous | – | This publication has no abstract. |
| ECT | Farricha et al · Melanoma Research | 2010 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Increased Intracellular Cisplatin Accumulation | 113 | – | bleomycin | – | Introduction We started to perform Electrochemotherapy (ECT) in Lisbon since February 2008. We initially treated mainly Melanoma patients but with the growing knowledge on this technique we … |
| ECT | Kyrgias et al · Melanoma Research | 2010 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Increased Intracellular Cisplatin Accumulation | 44 | – | – | – | Introduction ECT is based on the local delivery of electric pulses that causes transient permeabilisation of the cell membrane, facilitating the intracellular delivery of chemotherapeutic dr… |
| Other EP | Bonehill et al · Clin Cancer Res | 2009 | Clinical Study | Human | – | – | – | – | – | Purpose: A critical factor determining the effectiveness of currently used dendritic cell (DC)-based vaccines is the DC activation or maturation status. We have recently shown that the T-cel… |
| ECT | Campana et al · Ann Surg Oncol | 2009 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Muscle Contraction and Anaesthesia Requirement | 52 / 608 | Cliniporator | bleomycin · both intravenous and intratumoural | objective response 96% (52 patients) | Electrochemotherapy (ECT) has emerged as a complementary treatment for superficial metastases. Fifty-two consecutive patients with different cancer histotypes, mainly melanoma and breast can… |
| Other EP | Tauceri et al · Langenbecks Arch Surg | 2008 | Clinical Study | Human | – | 84 | Cliniporator | bleomycin · intratumoural | overall survival 72.1% (84 patients) | Background and aims: Survival rates of patients with stage IV melanoma are poor: Median survival is 7-8 months and 5-year survival rates about 5%. There is no agreement on the role of surger… |
| Gene ET | Daud et al · J Clin Oncol | 2008 | Clinical Study | Human | Gene Electrotransfer (Plasmid DNA), Interleukin-12 Mediated Immune Stimulation | 24 | MedPulser | plasmid DNA · intratumoural | complete response 2 count (19 patients) | Purpose: Gene-based immunotherapy for cancer is limited by the lack of safe, efficient, reproducible, and titratable delivery methods. Direct injection of DNA into tissue, although safer tha… |
| ECT | Quaglino et al · Ann Surg Oncol | 2008 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Potentiation of Cytotoxic Drug Permeability | 14 / 233 | – | bleomycin · intravenous | – | Background: Electrochemotherapy (ECT) combines chemotherapy and electroporation to increase drug uptake. Its role in cutaneous melanoma metastasis treatment is not well defined; indeed, few … |
| ECT | Gehl et al · Melanoma Res | 2000 | Clinical Study | Human | Haemostasis and Bleeding Control, Increased Intracellular Bleomycin Accumulation | 1 / 9 | BTX T820 square wave electroporator | bleomycin · intratumoural | complete response 100% (9 lesions) | Electric pulses can cause transient permeabilization of cell membranes (electroporation) and this can be utilized to increase the uptake of chemotherapy (electrochemotherapy). Preclinical st… |
| ECT | Rols et al · Melanoma Res | 2000 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation | 4 / 55 | PS 15 | bleomycin · intravenous | objective response 90% (55 lesions) | Electrochemotherapy is a new anticancer therapy in which transient permeabilization of cells by an electric field induces a significant increase in the bleomycin concentration and toxicity i… |
| ECT | Sersa et al · Clin Cancer Res | 2000 | Clinical Study | Human | Increased Intracellular Cisplatin Accumulation, Potentiation of Cytotoxic Drug Permeability | 10 / 133 | Jouan GHT 1287 | cisplatin · intratumoural | objective response 78% (82 lesions) | Electrochemotherapy consists of chemotherapy followed by local application of electric pulses to the tumor to increase drug delivery into the cells. The aim of this Phase II clinical study w… |
| ECT | Serša et al · Melanoma Res | 2000 | Clinical Study | Human | Increased Intracellular Cisplatin Accumulation, Potentiation of Cytotoxic Drug Permeability | – | Jouan GHT 1287 | cisplatin | – | The application of electric pulses to skin tumour nodules enhances the antitumour effectiveness of cisplatin. This treatment approach, known as electrochemotherapy, was employed in the treat… |
| ECT | Heller et al · Melanoma Research | 1997 | Clinical Study | Human | – | – | – | – | – | Heller, R; Jaroszeski, M; DeConti, R; Reintgen, D; Gilbert, R; Glass, F Author Information |
| ECT | Glass · Arch Dermatol | 1996 | Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Reversible Membrane Permeabilisation | 5 / 23 | T820 Electro Square Porator | bleomycin · intratumoural | complete response 78% (23 lesions) | Background Electroporation is a new technique that enhances the antitumor effects of chemotherapy by exposing cancerous tissues to pulses of electricity. When used in combination with conven… |
| ECT | Campana et al · Eur J Surg Oncol | 2025 | Retrospective Clinical Study | Human | Increased Intracellular Bleomycin Accumulation, Immune Checkpoint Inhibitor Combination | 452 | – | bleomycin · intravenous | objective response 63% (452 patients) | Background: This study analysed treatment strategies with electrochemotherapy (ECT) in melanoma with limb in-transit metastases (ITM). Methods: We audited AJCC v.8 stage IIIB-IIID patients t… |
| ECT | Siegmund et al · Cancers (Basel) | 2025 | Retrospective Clinical Study | Human | – | 11 / 66 | – | bleomycin · intravenous | – | Background/Objectives : Electrochemotherapy (ECT) has emerged as a promising locoregional treatment modality for patients with cutaneous and subcutaneous melanoma metastases. While systemic … |
| ECT | Campana et al · European Journal of Surgical Oncology | 2024 | Retrospective Clinical Study | Human | Immune Checkpoint Inhibitor Combination, Systemic / Abscopal Immune Response | 452 | – | bleomycin · intravenous | objective response 64% (452 patients) | Adjuvant BRAF/MEK inhibitors and immunotherapy with anti-PD-1 have become the standard of care for resected high-risk stage III and IV melanoma, but a head-to-head comparison in a clinical t… |
| ECT | Zdzienicki et al · J Clin Med | 2024 | Retrospective Clinical Study | Human | – | 88 | – | bleomycin · intravenous | complete response 45% (88 patients) | Background/Objectives : Despite observing progress in recent years in the treatment of patients with advanced melanoma, the optimal management of locoregional recurrence has not been determi… |
| ECT | Campana et al · Cancers (Basel) | 2021 | Retrospective Clinical Study | Human | Immune Checkpoint Inhibitor Combination, Immunogenic Cell Death (ICD) | 130 | – | bleomycin · both intravenous and intratumoural | local control 86% | Electrochemotherapy (ECT) is an effective locoregional therapy for cutaneous melanoma metastases and has been safely combined with immune checkpoint inhibitors in preliminary experiences. Si… |
| ECT | Guida et al · Cancers (Basel) | 2019 | Retrospective Clinical Study | Human | – | 27 | – | bleomycin · intravenous | overall survival 38 months (27 patients) | Background : A limited degree of progression after a response to treatment is labelled as oligoprogression and is a hot topic of metastatic melanoma (MM) management. Rogue progressive metast… |
| ECT | Heppt et al · Cancer Immunol Immunother | 2016 | Retrospective Clinical Study | Human | Immune Checkpoint Inhibitor Combination | 33 | Cliniporator, SENNEX | bleomycin · intravenous | local control 75.8% (33 patients) | Growing evidence suggests that concurrent loco-regional and systemic treatment modalities may lead to synergistic anti-tumor effects in advanced melanoma. In this retrospective multicenter s… |
| ECT | Hribernik et al · Radiol Oncol | 2016 | Retrospective Clinical Study | Human | – | 5 | Cliniporator | bleomycin · intravenous | complete response 85% (118 lesions) | Background: The combination of electrochemotherapy with immuno-modulatory treatments has already been explored and proven effective. However, the role of interferon alpha (IFN-α) adjuvant th… |
| ECT | Mozzillo et al · Oncoimmunology | 2015 | Retrospective Clinical Study | Human | Immune Checkpoint Inhibitor Combination, Increased Intracellular Bleomycin Accumulation | – | – | bleomycin · intravenous | – | Melanoma is responsible for most skin cancer-related deaths and is one of the most common cancers diagnosed in young adults. In melanoma, tumors can become established by activation of the n… |
| ECT | Solivetti et al · J Exp Clin Cancer Res | 2014 | Retrospective Clinical Study | Human | – | 15 / 52 | – | – | – | Background: Over the past several years the incidence of cutaneous melanoma has rapidly increased. This tumor develops often in-transit metastases that significantly reduce patient survival … |
| ECT | Testori et al · European Journal of Surgical Oncology | 2012 | Retrospective Clinical Study | Human | – | – | – | – | – | This publication has no abstract. |
| ECT | YazdanParast et al · Technol Cancer Res Treat | 2025 | Case Series | Human | – | 26 / 104 | OncoPore | bleomycin · intravenous | tumour volume change 100 count (26 patients) | PurposeThis study aimed to investigate the efficacy of electrochemotherapy on the three common types of skin cancer, including basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (… |
| ECT | Carrera et al · J Eur Acad Dermatol Venereol | 2013 | Case Series | Human | – | 8 | – | bleomycin · intravenous | local control 2 count (2 patients) | Background: Desmoplastic malignant melanoma (DMM) is a rare and usually misdiagnosed type of melanoma. Delayed detection at complicated anatomical locations can lead to the necessity of alte… |
| ECT | Kis et al · Dermatologic Surgery | 2011 | Case Series | Human | Increased Intracellular Bleomycin Accumulation, Muscle Contraction and Anaesthesia Requirement | 9 / 158 | Cliniporator | bleomycin · intravenous | objective response 62% (158 lesions) | OBJECTIVES Electrochemotherapy (ECT) is a novel therapeutic option for the treatment of cutaneous and subcutaneous metastases of malignant melanoma. During the treatment, electric pulses are… |
| ECT | Rózsa et al · J Dermatolog Treat | 2025 | Case Report | Human | Increased Intracellular Bleomycin Accumulation, Potentiation of Cytotoxic Drug Permeability | – / 2482 | Cliniporator | bleomycin · intravenous | – | Purpose: Lentigo maligna (LM), lentigo maligna melanoma (LMM), and acral lentiginous melanoma (ALM) are characterized by irregular borders and manifest on highly visible and/or surgically ch… |
| ECT | Carpenè et al · Eur Arch Otorhinolaryngol | 2024 | Case Report | Human | Muscle Contraction and Anaesthesia Requirement | 1 / 1 | – | bleomycin · intravenous | overall survival 17 months (1 patients) | Background: Sinonasal Mucosal Melanoma (SNMM) is a rare but aggressive disease. Surgery with free margins, when feasible, is the treatment of choice. In the last three decades, electrochemot… |
| ECT | Morgese et al · Mol Clin Oncol | 2023 | Case Report | Human | Immune Checkpoint Inhibitor Combination | 1 | – | bleomycin · intravenous | complete response 1 count (1 patients) | Immune checkpoint inhibitors have changed the natural history of advanced melanoma. Despite this, a notable proportion of patients immediately relapse or develop resistance during immunother… |
| Calcium EP | Vissing et al · Acta Oncol | 2023 | Case Report | Human | Calcium Electroporation and ATP Depletion, Immune Checkpoint Inhibitor Combination | 1 / 1 | Cliniporator | calcium chloride · intratumoural | complete response 1 count (1 patients) | Calcium electroporation (CaEP) has demonstrated promising results for local treatment of cutaneous metastases from breast cancer, melanoma, and head-and-neck cancer in initial clinical trial… |
| ECT | Landström et al · Melanoma Manag | 2022 | Case Report | Human | – | 1 / 1 | SENNEX | cisplatin · intratumoural | – | Despite the progress in immunotherapy and targeted therapy for patients with cutaneous malignant melanoma not all patients with loco-regional recurrences will respond to treatment. Electroch… |
| ECT | Russano et al · Oncol Lett | 2022 | Case Report | Human | Increased Intracellular Bleomycin Accumulation | 1 | Cliniporator | bleomycin · intravenous | – | The Buschke-Löwenstein tumor (BLT), also known as giant condyloma acuminatum, is a rare sexually transmitted disease often associated with human papillomavirus types 6 and 11. There are no s… |
| ECT | Quaresmini et al · Front Oncol | 2021 | Case Report | Human | Immune Checkpoint Inhibitor Combination | 1 | Cliniporator | bleomycin · intravenous | complete response 1 count (1 patients) | Background: Immunotherapy with immune checkpoint inhibitors is one of the main therapies for advanced melanoma. Nevertheless, albeit remarkable, immunotherapy results are still unsatisfactor… |
| ECT | Gallagher et al · JPRAS Open | 2020 | Case Report | Human | Increased Intracellular Bleomycin Accumulation, Reversible Membrane Permeabilisation | 2 | – | bleomycin | – | Bleomycin electrochemotherapy (ECT) has emerged as a treatment modality for locally advanced metastatic melanoma over the past decade. The phenomenon of reversible electroporation enhances c… |
| ECT | Saad et al · Eur J Plast Surg | 2020 | Case Report | Human | – | 1 / 1 | – | bleomycin | bleeding control 3 days (1 patients) | The management of sinister cutaneous lesions including malignant melanoma in the clinically frail patient tends to present clinicians with a professional and ethical dilemma on the optimal b… |
| ECT | Karaca et al · Anticancer Drugs | 2018 | Case Report | Human | Immune Checkpoint Inhibitor Combination | 1 / 1 | IGEA Cliniprator, Cliniporator | bleomycin · intravenous | complete response 1 count (1 patients) | Metastatic melanoma (MM) is one of the most lethal types of cancer. Although novel immunotherapeutics have been developed recently, still, these drugs fail to save the lives of a third of MM… |
| Calcium EP | Falk et al · Acta Oncol | 2017 | Case Report | Human | Calcium Electroporation and ATP Depletion, Systemic / Abscopal Immune Response | 1 / 100 | Cliniporator | bleomycin · intravenous | complete response 1 ratio (1 patients) | In this case study, we report a remarkable systemic response after treatment with electrochemotherapy and calcium electroporation in a patient with disseminated malignant melanoma.Electroche… |
| ECT | Brizio et al · Eur J Dermatol | 2015 | Case Report | Human | Immune Checkpoint Inhibitor Combination, Necrosis and Necroptosis | 1 / 28 | Cliniporator | bleomycin · intravenous | complete response 1 count (1 patients) | Skin metastases represent a relatively frequent event in the natural history of melanoma, developing both in early and in late disease stages. Cutaneous or subcutaneous lesions arise in 15-2… |
| ECT | Valpione et al · Radiol Oncol | 2015 | Case Report | Human | Increased Intracellular Bleomycin Accumulation | 1 / 3 | – | bleomycin · intravenous | local control 1 count (1 patients) | Background: Small molecules that inhibit V600 mutated BRAF protein, such as vemurafenib and dabrafenib, are effective in treatment of metastatic melanoma. Case report: We here describe the c… |
| ECT | Gasbarrini et al · Spine (Phila Pa 1976) | 2015 | Case Report | Human | Increased Intracellular Bleomycin Accumulation, Electric Field Distribution and Modelling | 1 / 1 | Cliniporator VITAE | bleomycin · intravenous | objective response 1% (1 patients) | Study design: Preliminary report of new antitumor treatment. Objective: To evaluate the effectiveness of electrochemotherapy as a novel treatment of spinal metastasis. Summary of background … |
| ECT | Mozzillo et al · J Transl Med | 2012 | Case Report | Human | Increased Intracellular Bleomycin Accumulation | 1 / 1 | – | bleomycin · intravenous | complete response 1 count (1 lesions) | Background: Approximately 200,000 new cases of melanoma are diagnosed worldwide each year. Skin metastases are a frequent event, occurring in 18.2% of cases. This can be distressing for the … |
| ECT | Miklavcic et al · Biomed Eng Online | 2010 | Case Report | Human | Electric Field Distribution and Modelling, Electrode Geometry and Placement | 1 / 1 | Cliniporator VITAE | bleomycin · intravenous | partial response 50% (1 patients) | Background: Electrochemotherapy treats tumors by combining specific chemotherapeutic drugs with an intracellular target and electric pulses, which increases drug uptake into the tumor cells.… |
| ECT | Snoj et al · Tumori | 2009 | Case Report | Human | Electrode Geometry and Placement, Increased Intracellular Bleomycin Accumulation | 1 / 1 | – | bleomycin · intravenous | bleeding control 1 count (1 patients) | Aims and background: Electrochemotherapy is an effective local treatment for tumors that combines administration of a chemotherapeutic drug with the subsequent application of electric pulses… |
| ECT | Snoj et al · Croat Med J | 2007 | Case Report | Human | Increased Intracellular Bleomycin Accumulation, Optimisation of Pulse Parameters | 1 / 224 | Cliniporator | bleomycin · intravenous | complete response 100% (42 lesions) | Multiple unresectable melanoma skin metastases pose a treatment problem, especially in centers where isolated limb perfusion is not available. We report the case of a 59-year-old woman who d… |
| ECT | Gehl et al · European Journal of Cancer Supplements | 2006 | Case Report | Human | Haemostasis and Bleeding Control | 1 / 8 | – | bleomycin · intravenous | complete response 7 ratio (8 lesions) | Increasing emphasis is being put on palliation of terminally ill cancer patients. Bleeding skin metastases are one of the many grievances that may negatively affect quality of life. In the s… |
| ECT | Snoj et al · European Journal of Cancer Supplements | 2006 | Case Report | Human | Increased Intracellular Cisplatin Accumulation | 1 / 16 | Jouan GHT 1287 | cisplatin · intratumoural | complete response 100% (16 lesions) | The optimal treatment of multiple cutaneous and subcutaneous metastases of melanoma still remains unresolved. There are many different possible treatment modalities. We present a case of mel… |
| ECT | Kubota et al · Melanoma Res | 2005 | Case Report | Human | – | 1 / 8 | – | bleomycin · intratumoural | complete response 3 count (3 lesions) | Kubota, Yoko; Tomita, Yoshihiko; Tsukigi, Masaaki; Kurachi, Hirohisa; Motoyama, Teiichi; Mir, Lluis M. Author Information |
| ECT | Snoj et al · Anticancer Drugs | 2005 | Case Report | Human | Increased Intracellular Cisplatin Accumulation | 1 / 1 | Cliniporator | cisplatin · intratumoural | tumour volume change 3.8 cm³ | Anorectal malignant melanoma is a rare tumor and there is no consensus on whether aggressive or local management is more appropriate. Local sphincter-saving excision has been shown to have a… |
| ECT | Vickars et al · Cureus | 2025 | Systematic Review / Meta-Analysis | Literature Analysis | – | – / 2482 | – | bleomycin | – | Electrochemotherapy (ECT) is a locoregional cancer treatment primarily used in the palliative management of cutaneous metastases from malignant melanoma. However, its clinical effectiveness,… |
| ECT | Milicevic et al · Int J Mol Sci | 2023 | Systematic Review / Meta-Analysis | Human | Immune Checkpoint Inhibitor Combination | 1 | – | bleomycin · intravenous | complete response 1 count (1 patients) | Cutaneous melanoma is a highly aggressive form of skin cancer. The development of immune checkpoint inhibitors (ICIs) has revolutionized the management of advanced melanoma, led to durable r… |
| ECT | Ferioli et al · Clin Exp Metastasis | 2022 | Systematic Review / Meta-Analysis | Human | Necrosis and Necroptosis | 529 / 2987 | – | – | overall survival 80.6% | The main treatment of MM metastases are systemic therapies, surgery, limb perfusion, and intralesional talimogene laherparepvec. Electrochemotherapy (ECT) is potentially useful also due to t… |
| ECT | Aguado-Romeo et al · Actas Dermosifiliogr | 2017 | Systematic Review / Meta-Analysis | Human | – | – | – | bleomycin · intravenous | objective response 60.2% (915 patients) | Electrochemotherapy is a therapeutic option for the treatment of cutaneous and subcutaneous metastases from melanoma and other tumors. The procedure consists of the administration of antican… |
| ECT | Campana et al · Br J Surg | 2023 | Guideline / Consensus | Human | – | 987 / 2482 | – | bleomycin | – | Background Skin metastases are an important co-morbidity in melanoma. Despite broad adoption, electrochemotherapy implementation is hindered by a lack of treatment indications, uncertainty r… |
| ECT | Campana et al · European Journal of Surgical Oncology | 2019 | Guideline / Consensus | Human | – | – | – | – | – | Electrochemotherapy (ECT) has evolved considerably over the past decade, but its application is yet to be standardized. In fact, a lack of agreement exists on eligible patients, timing of tr… |
| Gene ET | Ahmad et al · J Clin Med | 2024 | Review | Literature Analysis | Interleukin-12 Mediated Immune Stimulation, Systemic / Abscopal Immune Response | 987 / 2482 | – | – | – | Electroporation with chemotherapy (ECT) is currently offered as a treatment in Europe for locoregional or metastatic melanoma with cutaneous lesions. However, the role of surgery and other f… |
| Other EP | Criado-Otero et al · Cancers (Basel) | 2024 | Review | Literature Analysis | Interleukin-12 Mediated Immune Stimulation, Systemic / Abscopal Immune Response | – | – | other · both intravenous and intratumoural | – | Cutaneous melanoma is a malignant neoplasm with local and distant metastatic potential. When feasible, surgery is the first line of treatment in locoregionally advanced disease. Topical and … |
| Other EP | Russano et al · Cancers (Basel) | 2024 | Review | Literature Analysis | Immune Checkpoint Inhibitor Combination | – | – | bleomycin | objective response 80% | In-transit metastases (ITM) in melanoma present a significant therapeutic challenge due to their advanced stage and complex clinical nature. From traditional management with surgical resecti… |
| Other EP | Corvino et al · J Ultrasound Med | 2022 | Review | Human | – | – | – | bleomycin · intravenous | – | Cutaneous melanoma incidence is increasing worldwide, representing an aggressive tumor when evolving to the metastatic phase. High-resolution ultrasound (US) is playing a growing role in the… |
| IRE | Justesen et al · Cancers (Basel) | 2022 | Review | Literature Analysis | Irreversible Pore Formation and Cell Death, Reversible Membrane Permeabilisation | – | – | calcium chloride | – | The discovery of electroporation in 1968 has led to the development of electrochemotherapy (ECT) and irreversible electroporation (IRE). ECT and IRE have been established as treatments of cu… |
| ECT | Vega Díez et al · Actas Dermo-Sifiliográficas | 2022 | Review | Human | – | – | – | bleomycin · both intravenous and intratumoural | complete response 61% (987 patients) | ACTAS Dermo-Sifiliográficas 113 (2022) T817---T818 RESIDENT’S FORUM [Translated article] RF----Electrochemotherapy in the Treatment of Primary and Secondary Skin Tumors FR----Electroquimiotera… |
| ECT | Cucu et al · Materials (Basel) | 2021 | Review | Literature Analysis | Reversible Membrane Permeabilisation, Increased Intracellular Bleomycin Accumulation | 30 / 654 | – | bleomycin · intravenous | – | Electrochemotherapy (ECT) is an effective bioelectrochemical procedure that uses controlled electrical pulses to facilitate the increase of intracellular concentration of certain substances … |
| Other EP | Sagwal et al · Oxid Med Cell Longev | 2021 | Review | Animal (In Vivo) | Mitochondrial Dysfunction and Oxidative Stress | – | – | – | – | Metabolic energy production naturally generates unwanted products such as reactive oxygen species (ROS), causing oxidative damage. Oxidative damage has been linked to several pathologies, in… |
| Other EP | Ascierto · J Transl Med | 2018 | Review | Literature Analysis | Immune Checkpoint Inhibitor Combination | – | – | – | – | Metastatic melanoma represents a challenging clinical situation and, until relatively recently, there was an absence of effective treatment options. However, in 2011, the advanced melanoma t… |
| ECT | Goggins et al · Int J Dermatol | 2018 | Review | Human | – | – | – | bleomycin · intravenous | complete response 50% (52 patients) | Electrochemotherapy (ECT) is a treatment modality that combines low-dose chemotherapy with electroporation, thereby enhancing cytotoxicity. ECT was first utilized in the treatment of metasta… |
| ECT | Wichtowski et al · Contemp Oncol (Pozn) | 2018 | Review | Literature Analysis | Reversible Membrane Permeabilisation | – | – | bleomycin · intravenous | – | Electrochemotherapy is a new therapeutic option for patients with locally spread melanoma. It is based on the phenomenon of reversible electroporation, i.e. a transient increase in permeabil… |
| ECT | Cerio et al · Br J Dermatol | 2017 | Review | Human | – | – | – | bleomycin | objective response 77% (394 lesions) | Linked Article: Kunte et al. Br J Dermatol 2017; 176:1475–1485. |
| Other EP | Ascierto · J Transl Med | 2017 | Review | Human | Immune Checkpoint Inhibitor Combination | 30 | – | bleomycin | – | Major advances have been made in the treatment of cancer with targeted therapy and immunotherapy; several FDA-approved agents with associated improvement of 1-year survival rates became avai… |
| ECT | Campana et al · Handbook of Electroporation | 2017 | Review | Literature Analysis | – | – | – | bleomycin · both intravenous and intratumoural | – | Cutaneous metastases are not unusual in the clinical course of malignant melanoma, occurring in 2–20% of patients, depending on primary tumor features and disease stage. Patients with superfi… |
| ECT | Rutkowski et al · Melanoma Manag | 2014 | Review | Literature Analysis | Immune Checkpoint Inhibitor Combination, Systemic / Abscopal Immune Response | 34 | – | bleomycin · intravenous | overall survival 29 count (34 patients) | The majority of locoregional relapses of cutaneous melanoma occur as subcutaneous local recurrences/in-transit metastases; subcutaneous metastases (SMs) are also common in distant metastases… |
| ECT | Campana et al · J Surg Oncol | 2013 | Review | Animal (In Vivo) | – | – | – | bleomycin · intravenous | complete response 73.7% (41 patients) | Superficially metastatic melanoma still represents a challenging situation for oncologists and a distressing condition for patients. In this circumstance, local treatment by electrochemother… |
| ECT | Rastrelli et al · ISRN Dermatol | 2013 | Review | Human | – | – | – | bleomycin | – | This paper reviews the epidemiology, diagnosis, and treatment of M zero cutaneous melanoma including the most recent developments. This review also examined the main risk factors for melanom… |
| Other EP | Wong et al · N Am J Med Sci | 2013 | Review | Literature Analysis | – | – | – | cisplatin | tumour volume change 77% | Skin metastases are rare in the routine clinical practice of dermatology, but are of major clinical significance because they usually indicate advanced disease. We reviewed the literature on… |
| ECT | Testori et al · Curr Opin Oncol | 2012 | Review | Human | – | – | – | bleomycin · intravenous | complete response 73.7% (102 patients) | Purpose of review: In the present study, the role of electrochemotherapy (ECT) in the advanced melanoma setting, either as alternative treatment modality to conventional therapies or as pall… |
| ECT | Testori et al · Dermatol Ther | 2012 | Review | Literature Analysis | Systemic / Abscopal Immune Response | – | – | bleomycin · both intravenous and intratumoural | – | Nowadays, melanoma is one of the most common fatal malignancy of young adults. Incidence is increasing, but mortality rates from melanoma have remained stable. In-transit metastases from ext… |
| ECT | Good et al · J Am Acad Dermatol | 2011 | Review | Human | Increased Intracellular Bleomycin Accumulation | – | – | bleomycin · intratumoural | complete response 98% (54 lesions) | Intralesional agents have a role in the management of cutaneous malignancies. In this article, the efficacy, side effects, strengths, limitations, costs, and practical considerations regardi… |
| ECT | Testori et al · Treatment of Metastatic Melanoma | 2011 | Review | Literature Analysis | Systemic / Abscopal Immune Response | 52 | – | bleomycin · intravenous | complete response 66% (98 lesions) | About 68,130 new melanomas will be diagnosed in the United States during 2010 (38,870 men: 29,260 women) and of those 8,700 people will die of the disease (5,670 men; 3,030 women). The death… |
| Other EP | C. Heller et al · Curr Gene Ther | 2010 | Review | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Interleukin-12 Mediated Immune Stimulation | – | – | – | – | In vivo electroporation (EP) is a versatile delivery method for gene transfer which can be applied to any accessible tissue. Delivery of plasmid DNA encoding therapeutic genes or cDNAs with … |
| ECT | Möller et al · Expert Rev Anticancer Ther | 2009 | Review | Human | Increased Intracellular Bleomycin Accumulation, Increased Intracellular Cisplatin Accumulation | 52 / 40 | – | bleomycin · intravenous | – | Treatment of recurrent or in-transit unresectable melanoma continues to be a major therapeutic challenge. Electrochemotherapy (ECT) is a therapeutic option for those patients whose lesions a… |
| ECT | Byrne et al · Expert Rev Anticancer Ther | 2006 | Review | Human | Increased Intracellular Bleomycin Accumulation, Increased Intracellular Cisplatin Accumulation | – | – | bleomycin · intratumoural | objective response 85.3% (273 lesions) | Electroporation is a novel therapeutic modality that uses pulsed electrical currents to enhance the uptake of drugs, vaccines and genes into cells, and has been used for over 20 years. Elect… |
| ECT | Sersa · European Journal of Cancer Supplements | 2006 | Review | Literature Analysis | – | – / 1009 | – | bleomycin · intravenous | objective response 80% | The first clinical study on electrochemotherapy was published in 1991, reporting good treatment effectiveness of electrochemotherapy on cutaneous tumour nodules of head and neck tumours.1 Th… |
| ECT | Molina-Pineda et al · Pharmaceutics | 2026 | Animal Study | Animal (In Vivo) | Potentiation of Cytotoxic Drug Permeability | – | ELECTROvet EZ | other · intratumoural | complete response 1 count (1 animals) | Background/Objectives: Melanoma affects both sexes, and its incidence has increased in recent years. It is currently among the most common types of cancer. Standard chemotherapy, although ef… |
| ECT | Molina-Pineda et al · – | 2026 | Animal Study | Animal (In Vivo) | Potentiation of Cytotoxic Drug Permeability | – | ELECTROvet EZ | – | – | Background/Objectives: Melanoma affects both sexes, and its incidence has increased in recent years. It is currently among the most common types of cancer. Standard chemotherapy, although ef… |
| Gene ET | Brišar · Sci Rep | 2025 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | ELECTROcell B10 HVLV | plasmid DNA · intratumoural | – | Our study introduces a novel bacteriophage-based vaccine strategy and evaluates its antitumor efficacy, both as a standalone therapy and in combination with gene electrotransfer (GET) of int… |
| Other EP | Heller et al · Mol Ther Oncol | 2025 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | custom-built electrotransfer system | plasmid DNA · intratumoural | overall survival 80.89% (10 animals) | Interleukin-12 (IL-12) is a potent immune stimulator that induces the proliferation and activation of natural killer (NK) and T cells and the secretion of interferon (IFN)-γ. While IL-12 is … |
| Other EP | Kamenšek · Pharmaceutics | 2025 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | Cliniporator, GT-01 pulse generator | plasmid DNA | – | Background/Objectives : Mesenchymal stromal cells (MSCs) hold the potential for tumor-targeted gene delivery due to their ex vivo manipulability, low immunogenicity, scalability, and inheren… |
| ECT | Omerzel et al · Radiol Oncol | 2025 | Animal Study | Animal (In Vivo) | Optimisation of Pulse Parameters, Gene Electrotransfer (Plasmid DNA) | – | GeneDrive, Cliniporator | plasmid DNA · intratumoural | transfection efficiency 35% | Background: In recent years, various gene therapy strategies have been developed for cancer treatment. One of these strategies is electroporation-based delivery of therapeutic transgenes - g… |
| ECT | Uršič Valentinuzzi et al · Front Immunol | 2025 | Animal Study | Animal (In Vivo) | Systemic / Abscopal Immune Response, Increased Intracellular Bleomycin Accumulation | – | BetaTech, ELECTRO Cell B10 | bleomycin · intratumoural | – | Introduction: In addition to its direct cytotoxic effects, ablative therapies as electrochemotherapy (ECT) can elicit indirect antitumor effects by triggering immune system responses. Here, … |
| IRE | Wu et al · Cancer Immunol Immunother | 2025 | Animal Study | Animal (In Vivo) | Irreversible Pore Formation and Cell Death, Reversible Membrane Permeabilisation | – | custom-made IRE device | – | complete response 62.5% (8 animals) | Background: Melanoma is one of the deadliest forms of skin cancer. Irreversible electroporation (IRE) is an innovative, non-thermal ablation technology for treating irresectable solid cancer… |
| Calcium EP | Anastasova et al · Pharmaceuticals (Basel) | 2024 | Animal Study | Animal (In Vivo) | Increased Intracellular Bleomycin Accumulation, Calcium Electroporation and ATP Depletion | – | Cliniporator | other · intratumoural | – | Uveal melanoma (UM) represents a rare tumor of the uveal tract and is associated with a poor prognosis due to the high risk of metastasis. Despite advances in the treatment of UM, the mortal… |
| Gene ET | Heller · Mol Ther Nucleic Acids | 2024 | Animal Study | Animal (In Vivo) | Immune Checkpoint Inhibitor Combination, Interleukin-12 Mediated Immune Stimulation | – | BTX ECM830 | plasmid DNA · intratumoural | – | Interleukin-12 (IL-12) gene electrotransfer (GET) delivery is highly effective in inducing long-term, complete regression in mouse and human melanoma and other solid tumors. Therapeutic effi… |
| ECT | Mickevičiūtė et al · Int J Mol Sci | 2024 | Animal Study | Animal (In Vivo) | Reversible Membrane Permeabilisation, Optimisation of Pulse Parameters | – | – | calcium chloride · intratumoural | overall survival 14 days (6 animals) | The phenomenon known as bipolar cancellation is observed when biphasic nanosecond electric field pulses are used, which results in reduced electroporation efficiency when compared to unipola… |
| Calcium EP | Tsimpaki et al · Int J Mol Sci | 2024 | Animal Study | Animal (In Vivo) | Increased Intracellular Bleomycin Accumulation, Calcium Electroporation and ATP Depletion | – / 109 | Cliniporator | bleomycin · intratumoural | – | Despite recent advancements in the diagnosis and treatment of uveal melanoma (UM), its metastatic rate remains high and is accompanied by a highly dismal prognosis, constituting an unmet nee… |
| Gene ET | Ušaj · J Membr Biol | 2024 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Optimisation of Pulse Parameters | – | – | – | – | Cell-based therapies hold great potential for cancer immunotherapy. This approach is based on manipulation of dendritic cells to activate immune system against specific cancer antigens. For … |
| Calcium EP | Lisec et al · Front Immunol | 2023 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Increased Intracellular Bleomycin Accumulation | – | GT-01, ELECTRO cell B10 HVLV, Cliniporator | calcium chloride · intratumoural | complete response 18% | Introduction: In calcium electroporation (CaEP), electroporation enables the cellular uptake of supraphysiological concentrations of Ca 2+ , causing the induction of cell death. The effectiv… |
| Gene ET | Savarin · Int J Mol Sci | 2023 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Antivascular Effect and Vessel Disruption | – | ELECTRO CELL B10 | plasmid DNA · intratumoural | complete response 50% (8 animals) | Targeting the tumor vasculature through specific endothelial cell markers involved in different signaling pathways represents a promising tool for tumor radiosensitization. Two prominent tar… |
| Gene ET | Tellado et al · Vaccines (Basel) | 2023 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | EPV-200 | bleomycin · intravenous | objective response 80% (10 patients) | Electrochemotherapy (ECT) is a standard of care in veterinary and human oncology. The treatment induces a well-characterized local immune response which is not able to induce a systemic resp… |
| Gene ET | Kamensek · Heliyon | 2022 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | Cliniporator | – | – | Interleukin 12 (IL-12) is a cytokine used as a therapeutic molecule in cancer immunotherapy. Gene electrotransfer mediated delivery of IL-12 gene has reached clinical evaluation in the USA u… |
| ECT | Vizintin et al · Radiol Oncol | 2022 | Animal Study | Animal (In Vivo) | Increased Intracellular Cisplatin Accumulation, Optimisation of Pulse Parameters | – | laboratory prototype pulse generator | – · other route | – | Background: Nanosecond electric pulses showed promising results in electrochemotherapy, but the underlying mechanisms of action are still unexplored. The aim of this work was to correlate ce… |
| ECT | Brloznik et al · Sci Rep | 2021 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Interleukin-12 Mediated Immune Stimulation | – | ELECTRO CELL B10, Cliniporator | – · intratumoural | – | Electrochemotherapy with bleomycin (ECT BLM) is an effective antitumor treatment already used in clinical oncology. However, ECT alone is still considered a local antitumor therapy because i… |
| Gene ET | Savarin · Int J Mol Sci | 2021 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Antivascular Effect and Vessel Disruption | – | – | – | – | Targeting tumor vasculature through specific endothelial cell markers represents a promising approach for cancer treatment. Here our aim was to construct an antibiotic resistance gene-free p… |
| ECT | Chung et al · Cancers (Basel) | 2020 | Animal Study | Animal (In Vivo) | Reversible Membrane Permeabilisation | – | Cliniporator | bleomycin | – | The effectiveness of electrochemotherapy (ECT) in local eradication of tumours in human and veterinary medicine has been proven. ECT consists of increasing the uptake of cytotoxic drugs by m… |
| Gene ET | Kranjc · Vaccines (Basel) | 2020 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Reversible Membrane Permeabilisation | – | Cliniporator | other · intratumoural | – | The contactless high intensity pulsed electromagnetic field (HI-PEMF)-induced increase of cell membrane permeability is similar to conventional electroporation, with the important difference… |
| Gene ET | Kranjc · Vaccines (Basel) | 2020 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Potentiation of Cytotoxic Drug Permeability | – | GT-01, ELECTRO CELL B10 | plasmid DNA · intratumoural | complete response 81% (16 animals) | In this study, radiotherapy was combined with the gene electrotransfer (GET) of plasmid encoding shRNA against melanoma cell adhesion molecule (pMCAM) with dual action, which was a vascular-… |
| Gene ET | Remic · Vaccines (Basel) | 2020 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Interleukin-12 Mediated Immune Stimulation | – | – | plasmid DNA | – | Tumor cell-based vaccines use tumor cells as a source of tumor-associated antigens. In our study, we aimed to develop and test a tumor vaccine composed of tumor cells killed by irradiation c… |
| Gene ET | Shirley · Cancers (Basel) | 2020 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA) | – | BTX ECM830 | plasmid DNA · intratumoural | – | Gene electrotransfer (GET) is a safe, reliable, and effective method of delivering plasmid DNA (pDNA) to solid tumors. GET has been previously used to deliver interleukin-15 (IL-15) to mouse… |
| Calcium EP | Tremble · Sci Rep | 2020 | Animal Study | Animal (In Vivo) | Calcium Electroporation and ATP Depletion, Increased Intracellular Bleomycin Accumulation | – | BTX ECM 2001 | calcium chloride · other route | – | Electroporation in combination with chemotherapy is an established treatment used on solid malignancies that results in enhanced chemotherapeutic uptake. Recent advances have begun to transi… |
| Other EP | Pasquet et al · J Immunother Cancer | 2019 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Reversible Membrane Permeabilisation | – | – | plasmid DNA | – | Background: Melanoma is a very aggressive skin tumor that can be cured when diagnosed and treated in its early stages. However, at the time of identification, the tumor is frequently in a me… |
| ECT | Fiorentzis et al · Cancers (Basel) | 2019 | Animal Study | Animal (In Vivo) | – | – | Cliniporator | bleomycin · intratumoural | – | Uveal melanoma (UM) is the most common primary intraocular tumor that arises from neoplastic melanocytes in the choroid, iris, and ciliary body. Electrochemotherapy (ECT) has been successful… |
| Gene ET | Bosnjak · Cancers (Basel) | 2018 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA) | – | GT-01, ELECTRO cell B10 | plasmid DNA · intratumoural | complete response 1 ratio (12 animals) | Several studies have shown that different control plasmids may cause antitumor action in different murine tumor models after gene electrotransfer (GET). Due to the differences in GET protoco… |
| ECT | Groselj et al · Basic Clin Pharmacol Toxicol | 2018 | Animal Study | Animal (In Vivo) | Increased Intracellular Bleomycin Accumulation, Potentiation of Cytotoxic Drug Permeability | – / 6 | GT-01, Cliniporator | other · intravenous | tumour volume change 20.3 days (6 animals) | Pre-clinical and clinical data indicate differences in the responses of melanoma and carcinoma tumours to electrochemotherapy. The purpose of this study was to investigate the origin of this… |
| Other EP | Kamensek · Cancer Immunol Immunother | 2018 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | Electro Cell B10 | plasmid DNA · intratumoural | complete response 28.6% | Gene electrotransfer (GET) is one of the most efficient non-viral gene therapy approaches for the localized transfer of multiple genes into tumors in vivo; therefore, it is especially promis… |
| Gene ET | Kamensek et al · Cancers (Basel) | 2018 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | Electro Cell B10 | – | – | Plasmids, which are currently used in interleukin 12 (IL-12) gene electrotransfer (GET) clinical trials in the USA, contain antibiotic resistance genes and are thus, according to the safety … |
| Gene ET | Shi · Cancers (Basel) | 2018 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Interleukin-12 Mediated Immune Stimulation | – | – | plasmid DNA · intratumoural | – | Metastatic melanoma is an aggressive skin cancer with a relatively low survival rate. Immune-based therapies have shown promise in the treatment of melanoma, but overall complete response ra… |
| ECT | Ursic et al · Bioelectrochemistry | 2018 | Animal Study | Animal (In Vivo) | Increased Intracellular Cisplatin Accumulation, Immunogenic Cell Death (ICD) | – | GT-01, ELECTRO Cell B10 | other · intratumoural | tumour volume change 23 days (6 animals) | Interest in platinum-based chemotherapeutics such as oxaliplatin (OXA) and cisplatin (CDDP) has been reinvigorated by their newly described impacts on tumor-specific immune responses. In add… |
| Gene ET | Lampreht · Mediators Inflamm | 2017 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | ELECTRO cell B10 HVLV | plasmid DNA · intratumoural | – | Cancer immunotherapy is currently one of the leading approaches in cancer treatment. Gene electrotransfer of plasmids encoding interleukin 12 (IL-12) into the cells leads to the production o… |
| Gene ET | Savarin · Radiol Oncol | 2017 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA), Antivascular Effect and Vessel Disruption | – / 1 | ELECTRO CELL B10 | plasmid DNA · intratumoural | – | Background: Tumor irradiation combined with adjuvant treatments, either vascular targeted or immunomodulatory, is under intense investigation. Gene electrotransfer of therapeutic genes is on… |
| ECT | Kranjc et al · Radiol Oncol | 2016 | Animal Study | Animal (In Vivo) | Potentiation of Cytotoxic Drug Permeability, Optimisation of Pulse Parameters | – / 32 | TESLA Stym | cisplatin · intravenous | tumour volume change 2.3 days | Introduction: Pulsed electromagnetic field (PEMF) induces pulsed electric field, which presumably increases membrane permeabilization of the exposed cells, similar to the conventional electr… |
| Gene ET | Bosnjak et al · Gene Ther | 2015 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA) | – | ELECTRO CELL B10, Cliniporator, GT-01 | plasmid DNA · intratumoural | complete response 17% (18 animals) | Gene therapy with Plasmid AMEP (antiangiogenic metargidin peptide) has recently been studied as a potential targeted therapy for melanoma. This plasmid is designed to downregulate α5β1 and α… |
| Gene ET | Dolinsek et al · Cancers (Basel) | 2015 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA) | – | ELECTRO CELL B10 | plasmid DNA · intratumoural | complete response 23% (12 animals) | Endoglin overexpression is associated with highly proliferative tumor endothelium and also with some tumors, including melanoma. Its targeting has anti-tumor effectiveness, which can also be… |
| Gene ET | Forde · Gene Ther | 2015 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | ePORE | plasmid DNA · intratumoural | – | Antitumour efficacy of electroporated pEEV, coding for granulocyte-macrophage colony-stimulating factor and the B7-1 costimulatory immune molecule (pEEVGmCSF-b7.1) in growing solid tumours, … |
| Gene ET | Forde · Cancer Gene Ther | 2014 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA) | – | ePORE | plasmid DNA · intratumoural | – | Regulatory T cells (T-regs) can negatively impact tumor antigen-specific immune responses after infiltration into tumor tissue. However, depletion of T-regs can facilitate enhanced anti-tumo… |
| Gene ET | Shirley et al · Curr Gene Ther | 2014 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation, Gene Electrotransfer (Plasmid DNA) | – | BTX ECM830 | plasmid DNA | – | Effective delivery still remains a major hurdle in the development of gene based therapies. While technological advances have occurred that have improved delivery in general, there is still … |
| ECT | Daeschlein et al · Exp Dermatol | 2013 | Animal Study | Animal (In Vivo) | Increased Intracellular Bleomycin Accumulation, Electric Field Distribution and Modelling | – | Cliniporator | bleomycin · intravenous | – | The study was undertaken to compare antitumor efficacy of electrochemotherapy (ECT) with cold plasma therapy (CP) in a melanoma mouse model. After melanoma implantation into the flank of C57… |
| Other EP | Sin et al · Cancer Immunol Immunother | 2012 | Animal Study | Animal (In Vivo) | Interleukin-12 Mediated Immune Stimulation | – | Cellectra | plasmid DNA · intratumoural | complete response 10 count (15 animals) | Intratumoral electroporation (IT-EP) with IL-12 cDNA (IT-EP/IL12) can lead to the eradication of established B16 melanoma tumors in mice. Here, we explore the immunological mechanism of the … |
| Other EP | Spugnini et al · J Transl Med | 2011 | Animal Study | Animal (In Vivo) | Apoptosis Induction, Increased Intracellular Cisplatin Accumulation | – / 8 | Chemopulse | other · intravenous | tumour volume change 50% (8 patients) | Background: Nucleic acids designed to modulate the expression of target proteins remain a promising therapeutic strategy in several diseases, including cancer. However, clinical success is l… |
| Other EP | Lladser et al · Cancer Immunol Immunother | 2009 | Animal Study | Animal (In Vivo) | Gene Electrotransfer (Plasmid DNA) | – | Derma Vax™ DNA vaccine Skin Delivery System | – · intratumoural | – | Survivin is an intracellular tumor-associated antigen that is broadly expressed in a large variety of tumors and also in tumor associated endothelial cells but mostly absent in differentiate… |
| Other EP | Kang et al · Cancer Lett | 2008 | Animal Study | Animal (In Vivo) | – | – | Gene Pulser Xcell, CUY 21 Electroporator | plasmid DNA | local control 0% (3 samples) | Electroporation is a useful means for non-viral gene delivery. Here, we investigated the use of electroporation to deliver polymer-DNA complexes into living cells using a protein kinase C (P… |
| Other EP | Spugnini et al · Microsc Res Tech | 2007 | Animal Study | Animal (In Vivo) | – | – | Chemopulse | – | – | Electroporation (EP) has been widely employed in the past years as a safe and effective technique to drive drugs and DNA plasmids into target cells both for experimental and therapeutic purp… |
| Other EP | McCray et al · Mol Ther | 2006 | Animal Study | Animal (In Vivo) | Apoptosis Induction | – | BTX T820 pulse generator, autoswitcher, custom-made applicator containing six penetrating electrodes | plasmid DNA · intratumoural | complete response 14.29% (14 animals) | Novel therapies and delivery methods directed against malignancies such as melanoma, and particularly metastatic melanoma, are needed. The HIV-1 accessory protein Vpr (viral protein R) has p… |
| Other EP | Ayyavoo et al · Molecular Therapy | 2004 | Animal Study | Animal (In Vivo) | Apoptosis Induction | – | – | plasmid DNA · intratumoural | complete response 20% | Melanoma is an aggressive form of skin cancer. Effective treatment of this disease requires the development of new therapeutic strategies. One promising strategy is treatment of the tumor wi… |
| ECT | Entin et al · Clin Cancer Res | 2003 | Animal Study | Animal (In Vivo) | Increased Intracellular Bleomycin Accumulation, Apoptosis Induction | – | Grass S48 Stimulator | – · intratumoural | – | Purpose: The exposure of cells in vitro to trains of low voltage-pulsed electric fields in the range of 20-100 V/cm was previously shown to induce an efficient uptake of macromolecules with … |
| ECT | Heller et al · Melanoma Res | 2000 | Animal Study | Animal (In Vivo) | – | – | CytoPulse PA4000, CytoPulse PA4000 DC pulse generator | bleomycin · intratumoural | complete response 12.5% (8 animals) | When cancer cells, including melanoma cells, are genetically altered to secrete cytokines, irradiated and injected into subjects, long-term antitumour immunity is induced. Optimally, existin… |
| ECT | Heller et al · Melanoma Res | 1997 | Animal Study | Animal (In Vivo) | Increased Intracellular Bleomycin Accumulation, Electric Field Distribution and Modelling | – | – | – | – | Electrochemotherapy (ECT), chemotherapy administered in combination with electric fields, has the potential to be an effective localized treatment for cutaneous malignancies. Bleomycin's cyt… |
| Other EP | Heller et al · Bioelectrochemistry and Bioenergetics | 1995 | Animal Study | Animal (In Vivo) | Reversible Membrane Permeabilisation | – | T820 DC generator | bleomycin · intravenous | complete response 20 count (35 animals) | This publication has no abstract. |
| IRE | Blažič et al · Sci Rep | 2025 | In Vitro Study | Cell Culture | Reversible Membrane Permeabilisation, Irreversible Pore Formation and Cell Death | – | L-POR | – | – | High-intensity pulsed electric fields induce transient increase in membrane permeability, a phenomenon known as electroporation, with broad applications in medicine, including electrochemoth… |
| ECT | Coskun et al · Bioelectricity | 2024 | In Vitro Study | Cell Culture | Electric Field Distribution and Modelling | – | BTX ECM830 | other | cell viability 79% | Electrochemotherapy (ECT) involves locally applying electrical pulses to permeabilize cell membranes, using electroporation (EP). This process enhances the uptake of low-permeant chemotherap… |
| ECT | Heinzelmann et al · J Clin Med | 2023 | In Vitro Study | Cell Culture | Increased Intracellular Bleomycin Accumulation, Apoptosis Induction | – | Cliniporator | bleomycin · other route | – | Background: Conjunctival melanoma (CM) is associated with a high rate of local recurrence and poor survival rate. Novel therapeutic options are needed to reduce recurrence rate. The objectiv… |
| IRE | Lv et al · IEEE Trans Biomed Eng | 2023 | In Vitro Study | Cell Culture | Increased Intracellular Bleomycin Accumulation, Reversible Membrane Permeabilisation | – | Zhengzhou University prototype pulse generator | bleomycin · both intravenous and intratumoural | – | Hundreds of high frequency bipolar pulse bursts with ∼1 μs have been suggested to alleviate muscle contractions and pain during the irreversible electroporation (IRE) tumor treatment. This s… |
| Calcium EP | Kraemer et al · Cancers (Basel) | 2022 | In Vitro Study | Cell Culture | Increased Intracellular Bleomycin Accumulation, Calcium Electroporation and ATP Depletion | – | Genedrive, Genedrive voltage pulse generator | calcium chloride | – | Electrochemotherapy (ECT) is the combination of transient pore formation following electric pulse application with the administration of cytotoxic drugs, which enhances the cytotoxic effect … |
| Other EP | Rao et al · Sci Rep | 2022 | In Vitro Study | Cell Culture | Nanosecond Pulsed Electric Field (nsPEF), Irreversible Pore Formation and Cell Death | – | self-developed digital pulse generator | – | – | Microsecond pulsed electric fields (PEF) have previously been used for various tumour therapies, such as gene therapy, electrochemotherapy and irreversible electroporation (IRE), due to its … |
| ECT | Fiorentzis et al · Cancers (Basel) | 2021 | In Vitro Study | Cell Culture | Increased Intracellular Bleomycin Accumulation, Potentiation of Cytotoxic Drug Permeability | – | Genedrive | bleomycin | – | Electrochemotherapy (ECT) is emerging as a complementary treatment modality for local tumor control in various cancer entities. Irradiation is an established therapeutic option for oncologic… |
| Other EP | Choromanska et al · Pharmaceutics | 2020 | In Vitro Study | Cell Culture | Reversible Membrane Permeabilisation, Mitochondrial Dysfunction and Oxidative Stress | – | BTX ECM830 | other | – | Melanoma is one of the most serious skin cancers. The incidence of this malignant skin lesion is continuing to increase worldwide. Melanoma is resistant to chemotherapeutic drugs and highly … |
| ECT | Fiorentzis et al · Biomedicines | 2020 | In Vitro Study | Cell Culture | Increased Intracellular Bleomycin Accumulation, Optimisation of Pulse Parameters | – | – | bleomycin | – | Three-dimensional (3D) cell cultures represent small avascular tumors in vitro and simulate some of the biological characteristics of solid tumors, enhancing the evaluation of anticancer dru… |
| IRE | Szlasa et al · Molecules | 2020 | In Vitro Study | Cell Culture | Irreversible Pore Formation and Cell Death, Mitochondrial Dysfunction and Oxidative Stress | – | BTX ECM830 | – | – | Irreversible electroporation (IRE) is today used as an alternative to surgery for the excision of cancer lesions. This study aimed to investigate the oxidative and cytotoxic effects the cell… |
| ECT | Fiorentzis et al · Acta Ophthalmol | 2019 | In Vitro Study | Cell Culture | Increased Intracellular Bleomycin Accumulation | – | – | bleomycin | cell viability 6.5% (3 samples) | Purpose: To investigate the cytotoxic effect of bleomycin, mitomycin C (MMC) and Fluorouracil (5-FU) in combination with electroporation (EP) on human conjunctival melanoma (CM) and normal c… |
| ECT | Scuderi et al · Radiol Oncol | 2019 | In Vitro Study | Cell Culture | Increased Intracellular Cisplatin Accumulation, Muscle Contraction and Anaesthesia Requirement | – | BetaTech | cisplatin | cell viability 32.16% (1 not reported) | Background In electrochemotherapy (ECT), chemotherapeutics are first administered, followed by short 100 μs monopolar pulses. However, these pulses cause pain and muscle contractions. It is … |
| Other EP | Choromanska et al · Bioelectrochemistry | 2018 | In Vitro Study | Cell Culture | Reversible Membrane Permeabilisation | – | Gene Pulser Xcell | other | cell viability 43% | There are still not specified mechanisms how beta-glucan molecules are transported into cells. Supposing, beta-glucan toxicity against tumor cells may be related to the overexpression of the… |
| ECT | Fiorentzis et al · Neoplasma | 2018 | In Vitro Study | Cell Culture | Increased Intracellular Cisplatin Accumulation, Increased Intracellular Bleomycin Accumulation | – | Cliniporator | bleomycin | cell viability 74% | Electrochemotherapy (ECT) enhances responsiveness to cytotoxic drugs in numerous cell lines in vitro. Clinically ECT is widely applied for skin tumor ablation and has shown efficacy in treat… |
| ECT | Dolinsek et al · Radiol Oncol | 2016 | In Vitro Study | Cell Culture | Increased Intracellular Bleomycin Accumulation, Potentiation of Cytotoxic Drug Permeability | – | GT-01 | bleomycin | – | Background: The aim of the study was to explore the effectiveness of electrochemotherapy (ECT) during the treatment of melanoma patients with BRAF inhibitors. Its effectiveness was tested on… |
| Other EP | Kulbacka et al · Cell Stress Chaperones | 2013 | In Vitro Study | Cell Culture | Mitochondrial Dysfunction and Oxidative Stress | – | BTX ECM830, Petri Pulser applicator | other | – | Two porphyrins, CoTPPS and MnTMPyPCl5, were tested for their photodynamic activity and potential novel use in a therapy of human cancers. We investigated an effect of photodynamic reaction (… |
| ECT | Gerlini et al · Clin Exp Metastasis | 2012 | In Vitro Study | Cell Culture | – | 9 | – | bleomycin · intravenous | – | Electrochemotherapy (ECT) is a novel treatment for recurrent or in-transit unresectable melanoma metastases based on the administration of anti-neoplastic drugs followed by cancer cell elect… |
| ECT | Todorovic et al · Radiol Oncol | 2012 | In Vitro Study | Cell Culture | Increased Intracellular Bleomycin Accumulation | – | in-house build electroporator | bleomycin | – | Background: Electrochemotherapy is a local treatment combining chemotherapy and electroporation and is highly effective treatment approach for subcutaneous tumours of various histologies. Co… |
| ECT | Todorovic et al · Melanoma Res | 2011 | In Vitro Study | Human | Increased Intracellular Cisplatin Accumulation, Increased Intracellular Bleomycin Accumulation | – | – | cisplatin | – | Electrochemotherapy is a local treatment combining chemotherapy and application of electric pulses to the tumour. Electrochemotherapy with bleomycin and cisplatin has shown its effectiveness… |
| Gene ET | Mlakar et al · BMC Cancer | 2009 | In Vitro Study | Cell Culture | Gene Electrotransfer (Plasmid DNA), Apoptosis Induction | – | GT-1 electroporator | – | – | Background: Electroporation is a versatile method for in vitro or in vivo delivery of different molecules into cells. However, no study so far has analysed the effects of electric pulses use… |
| IRE | Mandel et al · PLoS One | 2013 | Experimental Biophysics Study | Human | Irreversible Pore Formation and Cell Death, Tissue Conductivity and Impedance Change | – / 5 | BTX ECM830 | – | – | Uveal melanoma (UM) is the most common primary intraocular tumor in adults and is characterized by high rates of metastatic disease. Although brachytherapy is the most common globe-sparing t… |
| Other EP | Fania et al · Discov Oncol | 2021 | Survey / Field Study | Human | – | 110 | – | bleomycin · intratumoural | – | Non-melanoma skin cancers include basal and squamous cell carcinoma. These tumors have become an important health issue for their high incidence and for the morbidity, especially if untreate… |
| Other EP | Ascierto et al · J Transl Med | 2022 | Conference Abstract | Literature Analysis | Potentiation of Cytotoxic Drug Permeability, Immune Checkpoint Inhibitor Combination | 60 | – | – | – | Advances in immune checkpoint and combination therapy have led to improvement in overall survival for patients with advanced melanoma. Improved understanding of the tumor, tumor microenviron… |
| ECT | Choromańska et al · Adv Clin Exp Med | 2023 | Editorial / Letter | Human | Increased Intracellular Bleomycin Accumulation | – | – | bleomycin · intravenous | – | The cell membrane can be permeabilized when subjected to calibrated short electric pulses. This membrane alteration can be reversible, leaving cell viability unaffected. This set of events i… |
| ECT | Bastrup et al · Acta Oncol | 2022 | Editorial / Letter | Human | – | – | – | – | – | Electrochemotherapy (ECT) is a treatment method, which uses electroporation to permeabilize the cell membrane and improve the delivery of chemotherapy into cells, thus increasing the cytotox… |
| ECT | Gerlini et al · Oncoimmunology | 2012 | Editorial / Letter | belirsiz | – | – | – | bleomycin | – | Combining electrochemotherapy with dendritic cell-based immunotherapy is a promising strategy against human metastatic melanoma that deserves to be clinically assessed. While electrochemothe… |
| ECT | Quaglino et al · Pigment Cell Melanoma Res | 2011 | Editorial / Letter | Human | – | 15 | Cliniporator | bleomycin · intravenous | objective response 8 ratio (15 patients) | , Electrochemotherapy (ECT) represents a new therapeutic option for primary and metastatic skin tumours (Mir et al., 2006). In recent years, many studies have shown its clinical efficacy in … |
| ECT | Giraud et al · Int J Radiat Oncol Biol Phys | 1996 | Editorial / Letter | Human | – | 4 / 58 | PS 15 | bleomycin · intravenous | complete response 4 count (58 lesions) | Infusional brachytherapy, the use of macroaggregated albumin and colloidal 32P in solid tumors, has been easy to reproduce in the clinic in Uppsala, Sweden; Brussels, Belgium; Seoul, Korea; … |
| ECT | Campana et al · Eur J Surg Oncol | 2025 | Correction / Erratum | – | – | – | – | – | – | European Journal of Surgical Oncology 51 (2025) 111158 Contents lists available at ScienceDirect European Journal of Surgical Oncology journal homepage: www.ejso.com Corrigendum to “Treatmen… |
No publication matches these filters.
Limitations
Publication volume is not clinical efficacy or evidence quality. It describes how much literature exists in the area and of what kind; it does not indicate how strongly the treatment is supported, guideline endorsement or regulatory status.
Patient totals are not a count of unique patients. The same cohort may have been reported in more than one publication; the totals are not a meta-analysis.
How the corpus was assembled, the tier thresholds, the definition of a clinical publication and why methods are counted separately: Literature Map.